re: Ann: Bank Facility Terms Renegotiated and... http://www.asx.com.au/asxpdf/20100407/pdf/31pn5yq14rb0y3.pdf
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%